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Abstract
The ability to introduce mutations, or transgenes, of choice to precise genomic locations has revolutionized our ability to understand how
genes and organisms work. In many mosquito species that are vectors of various human diseases, the advent of CRISPR genome editing
tools has shed light on basic aspects of their biology that are relevant to their efficiency as disease vectors. This allows a better understand-
ing of how current control tools work and opens up the possibility of novel genetic control approaches, such as gene drives, that deliber-
ately introduce genetic traits into populations. Yet for the Anopheles funestus mosquito, a significant vector of malaria in sub-Saharan
Africa and indeed the dominant vector species in many countries, transgenesis has yet to be achieved. We describe herein an optimized
transformation system based on the germline delivery of CRISPR components that allows efficient cleavage of a previously validated geno-
mic site and preferential repair of these cut sites via homology-directed repair (HDR), which allows the introduction of exogenous template
sequence, rather than end-joining repair. The rates of transformation achieved are sufficiently high that it should be able to introduce
alleles of choice to a target locus, and recover these, without the need to include additional dominant marker genes. Moreover, the high
rates of HDR observed suggest that gene drives, which employ an HDR-type mechanism to ensure their proliferation in the genome, may
be well suited to work in A. funestus.
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Introduction
Mosquitoes belonging to the genus Anopheles are vectors of a
range of agents of human disease, including viruses, parasitic
worms, and, most notably, malaria parasites. A way to introduce
defined genetic changes precisely into these insects can drasti-
cally improve our understanding of the genes responsible for key
traits that determine its capacity as a disease vector, such as par-
asite susceptibility, female reproductive output, human-biting
behavior, as well as helping in elucidating mechanisms of resis-
tance to insecticides. Moreover, the ability to introduce genes of
choice opens up the possibility of genetic control—the deliberate
introduction of traits into a mosquito population to reduce its ca-
pacity to transmit disease.
To date, most attention has focused on two members of the
Anopheles gambiae species complex, A. gambiae (s.s.) and Anopheles
coluzzi, which are the dominant vectors of human malaria across
most of sub-Saharan Africa, where malaria burden is highest.
However, Anopheles funestus, not a member of this species com-
plex, is the dominant vector in many places, notably in southerly
regions of sub-Saharan Africa, and insecticide resistance in this
species has been associated with local malaria resurgence there
and loss of efficacy of control interventions (Cohuet et al. 2004;
Riveron et al. 2019). Because the first demonstrations of a work-
ing, transposon-based transgenic technology for mosquitoes over
20 years ago, most of the major mosquito vectors have now been
transformed (Coates et al. 1998; Jasinskiene et al. 1998;
Catteruccia et al. 2000; Allen et al. 2001; Grossman et al. 2001), yet
A. funestus still remains the exception. This may in part simply
reflect the logistical difficulty associated with rearing this species
in the laboratory (Hunt et al. 2005; Morgan et al. 2010; Ngowo et al.
2021), but may also reflect a quirk in its biology that make it
more refractory to the process of germline transformation.
The prospects for transforming a mosquito species of choice
have been greatly improved by the general applicability of
CRISPR-Cas9 genome engineering tools to a wide range of species
(Gantz et al. 2015; Hammond et al. 2016; Purusothaman et al.
2021). CRISPR-mediated cleavage can be repaired via one of two
pathways: nonhomologous end-joining (NHEJ) repair and
homology-directed repair (HDR). Recently, CRISPR-mediated
cleavage was used to introduce random, heritable mutations via
NHEJ at specific sites in the genome of A. funestus (Li et al. 2018).
However, to date there still has been no documented report of
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HDR introduction (often referred to as “knock-in”) of either trans-
gene or specified pre-determined mutations, into this species.
This method relies on the provision of a DNA “donor” template
containing regions of homology on either side of the cut site,
designed in such a way that the cell’s HDR machinery uses it as a
template for repair, resulting in the incorporation of an allele or
transgene of choice. A method of this type is crucial for two rea-
sons: it would allow confirmation of genetic factors/signatures
identified in field populations that putatively confer important
phenotypes, such as insecticide resistance, with strong relevance
to control programs; it opens the door to novel genetic control
approaches, such as gene drive, which result in the specific intro-
duction and spread of transgenic traits into mosquito popula-
tions as a form of vector control.
The relative propensity for CRISPR-induced DNA breaks to be
repaired by HDR or NHEJ can show strong variation according to
whether the tissue is of somatic or germline origin, and even
within the germline it can be dependent on the level and timing
of Cas9 expression (Li et al. 2017; Kandul et al. 2020; Hammond
et al. 2021). For the purposes of generating stable transformed
mosquito strains it is essential that the CRISPR-induced modifi-
cations occur in the germline, so that they are transmitted to
their offspring from which a modified line can be established. We
have previously demonstrated high rates of CRISPR-mediated
HDR in generating transgenic A. gambiae by microinjecting em-
bryos with a plasmid-based source of Cas9 under a germline-
specific promoter together with a donor template designed to in-
corporate a dominant marker gene. Given this success in A. gam-
biae, we investigated whether a similar approach could work in A.
funestus, using components likely to work broadly across both
species.
Our experimental design allowed us to determine the relative
rates of NHEJ compared to HDR following Cas9 activity in injected
embryos. We were able to show rates of HDR-mediated germline
transformation comparable to those achieved for A. gambiae, sug-
gesting that the wealth of functional genetics tools and options
for genetic control that exist in that species may soon be avail-
able in A. funestus.
Materials and methods
Generation of transformation constructs for gene
targeting by CRISPR
The helper plasmid, containing source of Cas9 and guide RNA,
was a derivative of plasmid p165 (accession ID: KU189142)
(Hammond et al. 2016), containing a vasa2::SpCas9 construct and
a U6::gRNA cassette containing a spacer cloning site based on
Hwang et al. (2013). Oligos (forward—TGCTGGTGAGCTCCTT
GCGGTGAT; reverse—AAACATCACCGCAAGGAGCTCACC) were
designed to make a functional spacer targeting a previously vali-
dated target site in the A. funestus white gene (AFUN003538) (Li
et al. 2018) were annealed and cloned via BbsI Golden Gate cloning
into the spacer cloning site to produce helper plasmid p18.
The HDR “donor” construct contained regions of homology ap-
proximately 1 kb long immediately upstream and downstream of
the target cut site, amplified from pooled genomic DNA of A.
funestus mosquitoes (FANG strain, LSTM) with primer sets
designed for Gibson assembly of the two homology arms flanking
a dominant marker cassette, designed to express eCFP. Primer
sequences (sequences for Gibson cloning in small case) for the





TCCTTCAGAAC. The dominant marker cassette, containing an
enhanced cyan fluorescent protein (eCFP) unit under the promo-
tional control of the Drosophila Actin5c promoter (Han et al. 1989)
enclosed within two /C31 attP recombination sequences, was
amplified from plasmid pK104c (gift of K. Kyrou) using primers
kk047 (50-ACCGGTACCCCAATCGTTCA-30) and kk048 (50- ACGCG
TTCAGGATTATATCT-30). The homology arms and marker cas-
sette were cloned by Gibson assembly into MluI- and MshTI-
digested plasmid K103 (K. Kyrou), to generate the final donor
plasmid (p19).
Anopheles funestus rearing—insectary conditions,
microinjections, screening of transgenics
A large (>5000 adults) colony of A. funestus mosquitoes, FANG
strain (Hunt et al. 2005) is routinely held in insectaries at the
Liverpool Insect Testing Establishment (LITE), a dedicated GLP-
approved facility, adjoined to our host institution, for the contin-
uous production of mosquitoes and the testing of vector control
products. The FANG strain originated from Angola and is fully
susceptible to all insecticides (Hunt et al. 2005). For general main-
tenance, FANG colonies at LITE were provided a blood meal twice
prior to oviposition, using a Hemotek Membrane Feeding System
(Hemotek Ltd., Blackburn, UK), and with screened human blood
procured from NHS bloodbanks. In brief, eggs were floated in pu-
rified water with 0.01% w/v yeast hatching solution and reared at
larval densities of 0.24 larvae/mL. Larvae were fed increasing
amounts of ground TetraMinVR Tropical Flakes under the follow-
ing regime: day 1 (day of hatching) 100 mg/larvae; then day 2–7
200 mg/larvae; then day 8–10 233 mg/larvae, with day 10 being
the first day of pupation.
Prior to microinjection a cohort of mosquitoes (approximately
1500 adults) was maintained in dedicated insectary facilities ad-
jacent to the microinjection facility, at a temperature of
26C 6 2C, a relative humidity of 70 6 10%, and under an 11-
hours light/dark cycle with 1-hour dawn/dusk transitions.
Female mosquitoes were provided a blood meal from a human
volunteer in accordance with LSTM’s code of practice for arm-
feeding Anopheles mosquitoes. Gravid females were encouraged
to oviposit 60–96 hours after blood feeding by introducing them
into oviposition “chambers,” comprising of a 50 ml falcon tube
with the conical base removed, covered at one end with dual-
layered netting to create a secure way of entry, and plugged at
the other end with a shallow, concave plastic cap. Mosquitoes
were introduced inside the chambers in small groups (of approxi-
mately 10–15 individuals) and left to acclimatize in the dark for
at least 30 minutes before initiating oviposition by adding 2 ml
distilled H2O to the cap.
Embryos were injected using a modified version of the method
of Benedict (2007) as described previously (Fuchs et al. 2013).
Briefly, embryos were aligned against semi-moist nitrocellulose
paper, wet with distilled water, and injected into the posterior
pole at an oblique angle. The injection mix containing helper
(100 ng/ml) and donor plasmids (300 ng/ml) was resuspended in 1x
injection buffer (0.1 mM sodium phosphate buffer pH6.8; 10 mM
KCl). Following injection, eggs were floated in 1 L distilled water
and 0.01% w/v yeast solution, in plastic trays line with filter paper
around the waterline to prevent embryos adhering to the plastic
above the waterline and dessicating. Surviving G0 progeny were
screened for transient expression of eCFP or RFP at the 1st larval
instar and reared separately, accordingly as “transients” or
“nontransients.” We found the injection of A. funestus embryos
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slightly more challenging in terms of needle entry and survival,
compared to A. gambiae and Anopheles stephensi. Because it is cer-
tain that transient individuals were injected with a significant
amount of injection mix, we prioritized our efforts to maximize
the screening of the progeny of these individuals as opposed to
the nontransient larvae that may include a significant amount of
noninjected, or sub-optimally injected, individuals.
Early-stage larvae of the 1st and 2nd instars were fed 0.015%
TetraMinVR Baby fish food daily; 3rd and 4th instar larvae were
provided with 0.02% ground TetraMinVR Tropical Flakes. Once
transgenic colonies were established, larval trays were main-
tained at a density of 100–150 larvae per tray of size 30  30 cm.
G0 mosquitoes exhibiting transient fluorescent expression as
1st instar larvae were reared in separate groups of males or
females and mated to wild-type for 7 days before blood-feeding.
Subsequent generations were screened for actin5c::eCFP expres-
sion as mid-stage larvae; white-eye phenotypes and sex were
assessed at pupal stages. For G1, all white
CFP offspring were fe-
male and thus mated to wild-type males for 7 days before
blood-feeding. For G2, white
CFP offspring were outcrossed to wild-
type in separate groups of males or females. For G3, white
CFP off-
spring from whiteCFP G2 males (all female) were outcrossed to
wild-type, while whiteCFP offspring from whiteCFP G2 females
(males and females) were intercrossed together. Finally at G4, ho-
mozygous (white-eye, whiteCFP females) were crossed to whiteCFP
males in order to maintain transgene purity in following
generations.
T7 endonuclease assay
To assess for nonHDR mutagenic activity, G0 mosquitoes, exhibit-
ing transient fluorescent expression of the helper and donor plas-
mids, were first assessed for white-eye phenotypes under
standard brightfield microscopy. The genomic DNA (gDNA) of in-
dividual transient G0 mosquitoes was extracted using the
WizardVR Genomic DNA Purification Kit (Promega). In the T7
Endonuclease I (T7EI) assay, a 744 bp region spanning the cut-site
was first amplified by PCR (primer sequence forward—
GGCTGGTGTATGGTGAGTATG; reverse—GAAGAGCTACGGTTC
GGTTAAG). One microliter of T7EI (NEB) was then added to 19 ml
of purified (QIAquick PCR Purification Kit, QIAGEN) and hybrid-
ized PCR product containing approximately 200 ng of the PCR
product, digested for 15 minutes at 37C, and immediately visual-
ized on a 1% agarose electrophoresis stained with Midori Green
Advance (Nippon). T7 endonuclease-mediated cleavage of mis-
matched base pairs at the target site is expected to yield products
of approximately 518 and 226 bp.
Molecular genotyping
To molecularly characterize HDR knock-in events, the genomic
DNA (gDNA) of G1 and G2 mosquitoes fluorescently expressing
the actin5c::eCFP construct was extracted as individual samples
using the WizardVR Genomic DNA Purification Kit (Promega).
Regions of gDNA were then amplified according to the three
primer pairs as indicated in Figure 1. Briefly, the primer pairs am-
plified three regions localized to the insertion site within the white
gene: primer pair I (forward—GGTTAACGTATGCGGCAAACAC;
reverse—GTGTCGCCACCATCTGTGGTAAG) flanked the full in-
sertion region including the 5’ and 3’ homology arms, amplifying
a product of 3985 bp in individuals containing the whiteCFP allele
or 2302 bp in wild-type individuals; primer pair II [forward—
GGTTAACGTATGCGGCAAACAC (as in primer pair I); reverse—
CGACAACCACTACCTGAGC], which spanned the 5’ region of the
insertion and amplified a product of 1625 bp in whiteCFP
individuals, and primer pair III [forward—GCAGATGAACT
TCAGGGTCAGC; reverse—GTGTCGCCACCATCTGTGGTAAG (as
in primer pair II)] which spanned the 3’ region of the insertion
and amplified a product of 1917 bp.
Data availability
The data generated as part of this study are available within the
Supplementary material available at G3 online.
Results
As a proof of principle, we determined to target the A. funestus X-
linked gene white, which when mutated produces a visible pheno-
type in the eye (Li et al. 2017), with an HDR template designed to
introduce a dominant fluorescent marker gene expressing cyan
fluorescent protein (eCFP) (Figure 1A). We produced a “helper”
plasmid containing the Cas9 gene under the control of the
germline-specific promoter of the A. gambiae vasa gene
(Papathanos et al. 2009). Given that this promoter sequence from
A. gambiae manages to confer germline expression even in the
distantly related mosquito Aedes aegypti (Akbari et al. 2014), we
reasoned that it should work similarly in A. funestus. The helper
plasmid also contained a construct producing a white-specific
guide RNA under transcriptional control of the U6 promoter
(Hammond et al. 2016).
Together with the helper plasmid we included an HDR “donor”
construct (Figure 1A) that contained, as a dominant marker the
gene encoding an enhanced version of the cyan fluorescent pro-
tein (CFP) under the transcriptional control of the actin5c pro-
moter from Drosophila melanogaster which has previously been
shown to work well in A. stephensi and A. gambiae (Catteruccia
et al. 2000; Bernardini et al. 2014). Again, given this demonstration
of conservation of the promoter activity across such a large evo-
lutionary distance, coupled with the ubiquitous use of eCFP as a
visual reporter in a range of species, we reasoned that these com-
ponents would function as a dominant marker cassette in
A. funestus.
We injected A. funestus eggs of the FANG strain (Hunt et al.
2005) following a standard microinjection protocol (Benedict
2007; Fuchs et al. 2012) containing only minor modifications. Over
four separate sets of injections, we aligned approximately 1700
embryos for injection. Among the embryos surviving the proce-
dure, we screened for those larvae showing visual expression of
either the CFP or RFP marker genes transiently from either the
helper or donor plasmids. Encouragingly, we were able to see ei-
ther RFP or CFP expression in 44 of 223 surviving larvae (19%,
Table 1), indicating that these marker genes, and their respective
transcriptional units, are suitably expressed in A. funestus cells,
at least from an episomal source of the injected plasmid. Since
this fraction of larvae (which we term “transient” G0) are sure to
have been injected successfully with a considerable quantity of
the transformation plasmids, and given that A. funestus can be
cumbersome to rear and cross generally, we focused the majority
of our efforts on maximizing the screening of their progeny,
rather than the “nontransients” that may represent noninjected,
or sub-optimally injected, G0 individuals.
We crossed G0 individuals to wild type and screened for the
presence of CFP-positive offspring—suggestive of a HDR-targeting
event in the germline of the parent. Across the injection sets,
from a total of 26 surviving adult G0 individuals, we recovered 3
separate founders that produced CFP-positive offspring (Figure
1C), representing a transformation rate of 11%, considering this
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class only (or 3% considering all G0, transient and nontran-
sient). Among the offspring of these founders, the ratio of trans-
genic to nontransgenic offspring was relatively high, ranging
from 14 to 43% (Table 1), suggesting that the transformation
event happens early in germline development when there are rel-
atively few germline stem cells. The fact that most individuals
were CFP-positive only (and not RFP-positive also) is consistent
with CRISPR-mediated HDR integration of the CFP cassette con-
tained within the regions of homology upstream and down-
stream of the target site. To confirm this, we performed a
diagnostic PCR using primers that bind the genomic target region
externally to the regions of homology contained in the donor
plasmid (Figure 1A). The presence of the complete CFP cassette at
the target locus and the precise nature of the integration at the 5’
and 3’ end of the construct was confirmed (Figure 1B), and we
named the allele thus generated as whiteCFP. Our expectation was
that the whiteCFP allele would represent a null allele, given that
indels at this target site result in a white-eye phenotype (Li et al.
2018). Indeed, since the white gene resides on the X chromosome,
hemizygous whiteCFP males had white eyes whereas heterozygous
Figure 1 Targeted disruption of the white gene (AFUN003538) by CRISPR-mediated HDR. (A) Schematic representation of the HDR knock-in process. DNA
repair is mediated through the concurrent microinjection of two plasmid assemblies: a “helper” plasmid, designed to induce a double-stranded break
(DSB) at the target locus upon expression, containing a source of Cas9 and gRNA under the control of the vasa2 and U6 promoters respectively; and a
“template” plasmid containing the insert region (an actin5c::eCFP cassette enclosed within two reversible /C31 attP recombination sequences) flanked
both 5’ and 3’ by regions of homology approximately 1 kbp upstream and downstream of the cut site. (B) Diagnostic PCRs of transgenic offspring (G2)
deriving from different founders. PCR primer binding sites are represented by triangles. “External” primers flanking the full insertion and binding outside
the regions of homology included in the donor construct (red and blue triangles, I) are used to discriminate between wild-type individuals and females
heterozygous or males hemizygous for the whiteCFP allele. “Internal” primers complementary to the knocked-in eCFP sequence (green and orange
triangles) are used with external primers to amplify the 5’ region upstream (II) or 3’ region downstream (III) of the eCFP cassette. Three separate
transgenic lines were produced and assigned according to injection set (A–D) and sex of founder individual or group (m—males or f—females). wt—wild-
type control. (C) Bright-field (left and right) or standard fluorescent (middle) microphotographs of representative individuals demonstrating either the
wild-type or whiteCFP mutant phenotype. Under bright-field illumination, mutant larvae (left) and pupae (right) exhibit lighter global pigmentation
compared to wild-type, and are white-eyed (arrows). Transgenic whiteCFP individuals additionally express cyan fluorescent protein from the actin5C
promoter, in a pattern (lower midgut and gastric caecae) consistent with the activity of this promoter in other Anopheles species (middle).
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females exhibited a wild-type eye color, confirming that the
whiteCFP allele is both recessive and, likely, null. Among the G1
progeny we also recovered a small fraction of offspring (3.8% of
all transgenic offspring) that were both RFPþ and CFPþ, suggest-
ing that in rare cases semi-legitimate recombination may occur,
inserting at least a section of the donor plasmid external to the
homology-flanked cassette that includes an RFP cassette in the
plasmid backbone (Figure 1A). However, we did not investigate
these rare events molecularly. The whiteCFP HDR allele showed
normal Mendelian inheritance and, in homozygosity in females,
resulted in a white eye phenotype (Supplementary Table S1).
One of our motivations for using a plasmid-based source of
Cas9 under a germline-specific promoter was to target Cas9 ac-
tivity to the germline where rates of HDR seem to be very high, in
Anopheles species at least, and to have a system that could mini-
mize somatic activity of the Cas9. Previously, it was shown that
while injection of a mix of Cas9 protein and gRNA could generate
indels at the target site in the germline, it also generated a mosaic
of somatic mutations in these individuals, including the muta-
tion of both alleles (bi-allelic mutations) in some cells, resulting
in eye color mosaicism in these G0 individuals (Li et al. 2018). On
the contrary, in the G0 individuals injected with the vasa-driven
source of Cas9 we failed to observe any eye color mosaicism in
males or females (Table 1). A T7 assay revealed that rates of end-
joining mutations were very low in injected individuals, to the
point where they were barely detectable (Supplementary Figure
S1). Indeed, in one founder that produced HDR-mediated trans-
genic offspring we failed to observe any signal of end-joining ac-
tivity in the T7 assay. Moreover, we also found no evidence of any
germline transmission of Cas9-generated indels (i.e., end-joining
repair events) from any of the founders—these indels would be
expected to result in a nonCFP, white-eyed phenotype in hemizy-
gous males, yet we failed to observe any such events among the
siblings of HDR-mediated transgenic offspring. Taken together,
these data support the hypothesis that this transformation proto-
col, using a germline-restricted source of Cas9, strongly favors
the generation of HDR-mediated repair over end-joining repair.
Discussion
This is the first report of the generation of transgenic A. funestus.
The availability of a CRISPR-based technology to introduce trans-
genes, or to introduce precise and defined changes, at specific ge-
nomic loci, has the potential transform our ability to perform
functional genetics in insects, such as exploring the function of
genes putatively controlling key phenotypes such as insecticide
resistance (Itokawa et al. 2016; Samantsidis et al. 2020), investigat-
ing genes that are essential for important insect behaviors (Raji
et al. 2019) or identifying genes that are important for key traits
such as immunity and female reproductive capacity (Hammond
et al. 2016).
For A. funestus, a pressing aspect to investigate is the nature of
its resistance to pyrethroid insecticides, a mainstay of
insecticide-treated bednets, where the resistance mechanism
appears to be different to that observed in A. gambiae and may in-
volve copy number variation, allelic variation of coding regions
and/or the insertion of cis-regulatory sequences that lead to
upregulation of expression (Ibrahim et al. 2015; Mugenzi et al.
2019; Weedall et al. 2019, 2020). A CRISPR-based HDR tool will be
crucial in investigating these hypotheses.
The high frequency with which transgenics were recovered us-
ing our approach means that it should be possible, by judicious
molecular genotyping of offspring, to recover precisely modified
mosquitoes without the need for insertion of a dominant marker
gene, that might have confounding effects on phenotype. Of
course, the efficiency of targeting may vary according to gRNA:
locus combination and additional future experiments will be im-
portant to confirm targeting rates across a range of loci. The rela-
tive rates of HDR vs end-joining repair following Cas9-induced
DNA breaks can vary according to cell type and between germline
and soma (Lin et al. 2014; Kandul et al. 2020; Hammond et al.
2021). In addition, there appears to be variation in the rates of
CRISPR-based transgenesis between species with the rates for A.
aegypti, for example, generally being significantly lower than
those observed in A. gambiae (Kistler et al. 2015; Hammond et al.
2016). However, it is difficult to disentangle effects due to differ-
ing biology between the species and effects due to different trans-
formation systems/setups. Indeed, the HDR transformation rates
were improved several fold in A. aegypti by injecting a line con-
taining a transgenic source of germline Cas9 (Li et al. 2017). Our
approach, of injecting a plasmid-based source of Cas9 active in
the germline coupled with a gRNA transcription unit has several
attractive features: it obviates the need to inject a Cas9-
expressing transgenic line; the plasmid-based DNA solution is
much less labile than protein/RNA-based mixtures; rates of HDR
are high; and the relative ratio of HDR: NHEJ events is very high,
as evidenced by the almost complete lack of somatic mosaicism
observed after injection. This latter aspect is particularly



























A 640 53 11 4 0 Transient #(3)  wt outcross 5 71/174 (42.5)
Transient $(1) wt outcross 0 0/0 (0)
NT#/$ intercross 1 0/130 (0)
B 350 68 7 4 0 Transient #(2)  wt outcross 1 0/21 (0)
Transient $(2)  wt outcross 0 0/0 (0)
NT#/$ intercross 1 0/55 (0)
C 420 40 12 7 0 Transient #(5)  wt outcross 4 90/564 (16.0)
Transient $(2)  wt outcross 4 20/140 (14.3)
NT#/$ intercross 1 0/61 (0)
D 300 72 14 11 0 Transient # (5)  wt outcross 0 0/0 (0)
Transient $(6)  wt outcross 2 0/73 (0)
NT#/$ intercross 1 0/75 (0)






/g3journal/advance-article/doi/10.1093/g3journal/jkab201/6303614 by guest on 02 August 2021
important if the target gene is essential and extensive mosaicism
might reduce the recovery of desired events.
Finally, an important consideration for the feasibility of gener-
ating gene drives, which are designed to bias their inheritance
among offspring and thereby spread linked traits into a popula-
tion (Alphey et al. 2020), are the relative rates of HDR vs NHEJ.
Homing-based gene drives (Burt 2003; Esvelt et al. 2014) have, to
date, shown the most promise in terms of development and
proof-of-principle demonstration in the laboratory, in a number
of mosquito species (Gantz et al. 2015; Hammond et al. 2016; Li
et al. 2020). This type of gene drive encodes a Cas9: gRNA unit
that cleaves germline chromosomes at an endogenous target se-
quence and hijacks the HDR pathway to copy itself into the
repaired site, thereby increasing its copy number. Thus, HDR is
essential for this type of gene drive to work. On the flip side, NHEJ
repair events following gene drive activity not only reduce the
probability of the drive copying itself directly but the small indels
can generate target sites that are resistant to future gene drive
targeting (Champer et al. 2017; Hammond et al. 2017). Therefore,
the high rates of HDR that we observed in A. funestus augur well
for the prospect of developing gene drives for control of this con-
siderable vector of malaria. This feature, coupled now with a ca-
pacity to perform functional genetics, should expand the range of
innovative control tools available and augment those that al-
ready exist.
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